Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats

Pharmacological Reports

Volumn 68, Issue 2, 2016, Pages 363-369

  Toczek, Marek ^a   Baranowska Kuczko, Marta ^a   Grzęda, Emilia ^a   Pędzińska Betiuk, Anna ^a   Weresa, Jolanta ^a   Malinowska, Barbara ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Age specific; Anandamide; DOCA salt hypertension; Endocannabinoid system; URB597

Indexed keywords

CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; AMIDASE; BENZAMIDE DERIVATIVE; CARBAMIC ACID DERIVATIVE; CYCLOHEXYL CARBAMIC ACID 3'-CARBAMOYLBIPHENYL-3-YL ESTER; DEOXYCORTICOSTERONE ACETATE; FATTY-ACID AMIDE HYDROLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEOXYCORTICOSTERONE-SALT INDUCED HYPERTENSION; FLUID INTAKE; FOOD INTAKE; HEART RATE; HEART VENTRICLE HYPERTROPHY; KIDNEY HYPERTROPHY; MALE; NONHUMAN; RAT; WEIGHT GAIN; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS; HEART; HYPERTENSION; HYPERTROPHY; KIDNEY; WISTAR RAT;

AMIDOHYDROLASES; ANIMALS; BENZAMIDES; BLOOD PRESSURE; CARBAMATES; DESOXYCORTICOSTERONE ACETATE; HEART; HEART RATE; HYPERTENSION; HYPERTROPHY; KIDNEY; MALE; RATS; RATS, WISTAR;

EID: 84954306232     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2015.10.004     Document Type: Article

References (42)

1. B. Malinowska, M. Baranowska-Kuczko, and E. Schlicker Triphasic blood pressure responses to cannabinoids: do we understand the mechanism? Br J Pharmacol 165 7 2012 2073 2088
2. P. Pacher, and G. Kunos Modulating the endocannabinoid system in human health and disease - successes and failures FEBS J 280 9 2013 1918 1943
3. M. Zubrzycki, A. Liebold, A. Janecka, and M. Zubrzycka A new face of endocannabinoids in pharmacotherapy. Part I: protective role of endocannabinoids in hypertension and myocardial infarction J Physiol Pharmacol 65 2 2014 171 181
4. D. Li, B.M. Chen, J. Peng, Y.S. Zhang, X.H. Li, Q. Yuan, and et al. Role of anandamide transporter in regulating calcitonin gene-related peptide production and blood pressure in hypertension J Hypertens 27 6 2009 1224 1232
5. S. Engeli, M. Blüher, R. Jumpertz, T. Wiesner, H. Wirtz, A. Bosse-Henck, and et al. Circulating anandamide and blood pressure in patients with obstructive sleep apnea J Hypertens 30 12 2012 2345 2351
6. W.J. Crawford, and J.C. Merritt Effects of tetrahydrocannabinol on arterial and intraocular hypertension Int J Clin Pharmacol Biopharm 17 5 1979 191 196
7. K.D. Lake, B.R. Martin, G. Kunos, and K. Varga Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats Hypertension 29 5 1997 1204 1210
8. S. Bátkai, P. Pacher, D. Osei-Hyiaman, S. Radaeva, J. Liu, Harvey-White, and et al. Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension Circulation 110 14 2004 1996 2002
9. W.S. Ho, and S.M. Gardiner Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats Br J Pharmacol 156 1 2009 94 104
10. G.D. Duerr, J.C. Heinemann, S. Dunkel, A. Zimmer, B. Lutz, R. Lerner, and et al. Myocardial hypertrophy is associated with inflammation and activation of endocannabinoid system in patients with aortic valve stenosis Life Sci 92 20-21 2013 976 983
11. Y. Lu, B.C. Akinwumi, Z. Shao, and H.D. Anderson Ligand activation of cannabinoid receptors attenuates hypertrophy of neonatal rat cardiomyocytes J Cardiovasc Pharmacol 64 5 2014 420 430
12. K.A. Jenkin, A.J. McAinch, E. Grinfeld, and D.H. Hryciw Role for cannabinoid receptors in human proximal tubular hypertrophy Cell Physiol Biochem 26 6 2010 879 886
13. P. Janiak, B. Poirier, J.P. Bidouard, C. Cadrouvele, F. Pierre, L. Gouraud, and et al. Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats Kidney Int 72 11 2007 1345 1357
14. Y. Wang, N.E. Kaminski, and D.H. Wang Endocannabinoid regulates blood pressure via activation of the transient receptor potential vanilloid type 1 in Wistar rats fed a high-salt diet J Pharmacol Exp Ther 321 2 2007 763 769
15. J. Schenk, and J.H. McNeill The pathogenesis of DOCA-salt hypertension J Pharmacol Toxicol Methods 27 3 1992 161 170
16. J. Zicha, Z. Dobešová, M. Vokurková, H. Rauchová, S. Hojná, M. Kadlecová, and et al. Age-dependent salt hypertension in Dahl rats: fifty years of research Physiol Res 61 Suppl. 1 2012 S35 S87
17. 1 receptors on sympathetic nerves of DOCA-salt hypertensive rats Life Sci 2015 pii:S0024-3205(15)00215-5
18. D. Piomelli, G. Tarzia, A. Duranti, A. Tontini, M. Mor, T.R. Compton, and et al. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597) CNS Drug Rev 12 1 2006 21 38
19. R.G. Pertwee Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications Proc Nutr Soc 73 1 2014 96 105
20. G. Godlewski, S.O. Alapafuja, S. Bátkai, S.P. Nikas, R. Cinar, L. Offertáler, and et al. Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects Chem Biol 17 11 2010 1256 1266
21. R. Sarzani, M. Bordicchia, F. Salvi, G. Cola, E. Franchi, I. Battistoni, and et al. A human fatty acid amide hydrolase (FAAH) functional gene variant is associated with lower blood pressure in young males Am J Hypertens 21 8 2008 960 963
22. V. Di Marzo, N. Stella, and A. Zimmer Endocannabinoid signalling and the deteriorating brain Nat Rev Neurosci 16 1 2015 30 42
23. T.T. Lee, M.N. Hill, C.J. Hillard, and B.B. Gorzalka Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period Synapse 67 1 2013 4 10
24. S.J. Ward, T.W. Lefever, S.M. Rawls, G.T. Whiteside, and E.A. Walker Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats Psychopharmacology (Berl) 206 1 2009 155 165
25. J. Zicha, J. Kunes, and J. Jelínek Experimental hypertension in young and adult animals Hypertension 8 12 1986 1096 1104
26. J. Zicha, J. Kunes, M. Lébl, I. Pohlová, and J. Jelínek Haemodynamics and the participation of pressor systems in young and adult rats with age-dependent DOCA-salt hypertension Physiol Bohemoslov 36 1 1987 89 92
27. B.N. Okine, L.M. Norris, S. Woodhams, J. Burston, A. Patel, S.P. Alexander, and et al. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system Br J Pharmacol 167 3 2012 627 640
28. N. Murphy, T.R. Cowley, C.W. Blau, C.N. Dempsey, J. Noonan, A. Gowran, and et al. The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation J Neuroinflammation 9 2012 79
29. A. Busquets-Garcia, E. Puighermanal, A. Pastor, R. de la Torre, R. Maldonado, and A. Ozaita Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses Biol Psychiatry 70 5 2011 479 486
30. J.L. Blankman, and B.F. Cravatt Chemical probes of endocannabinoid metabolism Pharmacol Rev 65 2 2013 849 871
31. S.G. Kinsey, P.S. Naidu, B.F. Cravatt, D.T. Dudley, and A.H. Lichtman Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice Pharmacol Biochem Behav 99 4 2011 718 725
32. M. Burnier, O. Phan, and Q. Wang High salt intake: a cause of blood pressure-independent left ventricular hypertrophy? Nephrol Dial Transplant 22 9 2007 2426 2429
33. I. Vaněčková, M. Vokurková, H. Rauchová, Z. Dobešová, O. Pecháňová, J. Kuneš, and et al. Chronic antioxidant therapy lowers blood pressure in adult but not in young Dahl salt hypertensive rats: the role of sympathetic nervous system Acta Physiol (Oxf) 208 4 2013 340 349
34. S. Bátkai, M. Rajesh, P. Mukhopadhyay, G. Haskó, L. Liaudet, B.F. Cravatt, and et al. Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase Am J Physiol Heart Circ Physiol 293 2 2007 H909 H918
35. C.L. Schaich, H.A. Shaltout, M. Grabenauer, B.F. Thomas, P.E. Gallagher, A.C. Howlett, and et al. Alterations in the medullary endocannabinoid system contribute to age-related impairment of baroreflex sensitivity J Cardiovasc Pharmacol 65 5 2015 473 479
36. A.I. Idris, A. Sophocleous, E. Landao-Bassonga, M. Canals, G. Milligan, D. Baker, and et al. Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells Cell Metab 10 2 2009 139 147
37. V.M. Pulgar, L.M. Yamaleyeva, J. Varagic, C.M. McGee, M. Bader, R. Dechend, and et al. Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis Hypertension 64 3 2014 619 625
38. J. Zicha, Z. Dobešová, J. Kuneš, and I. Vaněčková Chronic endothelin A receptor blockade attenuates contribution of sympathetic nervous system to salt hypertension development in adult but not in young Dahl rats Acta Physiol (Oxf) 205 1 2012 124 132
39. C.L. Schaich, H.A. Shaltout, K.B. Brosnihan, A.C. Howlett, and D.I. Diz Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats Physiol Rep 2 8. 2014 10.14814/phy2.12108 pii:e12108
40. P. Mukhopadhyay, B. Horváth, M. Rajesh, S. Matsumoto, K. Saito, S. Bátkai, and et al. Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury Free Radic Biol Med 50 1 2011 179 195
41. O. Gunduz-Cinar, M.N. Hill, B.S. McEwen, and A. Holmes Amygdala FAAH and anandamide: mediating protection and recovery from stress Trends Pharmacol Sci 34 11 2013 637 644
42. J.P. Huggins, T.S. Smart, S. Langman, L. Taylor, and T. Young An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee Pain 153 9 2012 1837 1846